News
Truist notes that AnaptysBio (ANAB) reported the “much anticipated” results of its Phase 2b trial of rosnilimab for moderate-to-severe rheumatoid arthritis and that the primary endpoint of DAS ...
AnaptysBio, Inc. (ANAB) shares rallied 9.5% in the last trading session to close at $18.71. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
ISR (NSF), a leading global public health and safety organization, is pleased to announce that it has become the first ANSI ...
In addition to being only one of two companies in the world accredited by the ANSI National Accreditation Board (ANAB) to provide HRL2 level testing, SMT is also on the DLA QTSL for testing un ...
AnaptysBio (ANAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in ...
AnaptysBio, Inc. (ANAB) shares rallied 9.5% in the last trading session to close at $18.71. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund 301.67k Dec 31, 2024 0.98% 5,716,646 Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund 269.44k Dec 31, 2024 0.88% ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results